Skip to main content

Table 2 Scores of the thirty one statements written in the leaflets inserted in the local and imported NSAIDs

From: Comparative evaluation of drug information leaflets for non-steroidal anti-inflammatory drugs in Palestine: local versus imported products

Local Companies
No.CriteriaA (N = 7)B (N = 5)C (N = 5)D (N = 1)Total scores of Local products (N = 18)Total scores of Imported products (N = 17)Total (N = 35)
1.Brand name755118 (100)17 (100)35 (100)
2.Active ingredient755118 (100)17 (100)35 (100)
3.Inactive ingredients (excipients)00000 (0)17 (100)17 (49)
4.Therapeutic class445114 (78)17 (100)31 (89)
5.Mechanism of action01203 (17)3 (18)6 (17)
6.Indications755118 (100)17 (100)35 (100)
7.Drug dose534113 (72)14 (82)27 (77)
8.Duration of using20215 (28)12 (71)17 (49)
9.Missing dose741113 (72)11 (65)24 (69)
10.Maximum dose525113 (72)14 (82)27 (77)
11.Directions for use755118 (100)17 (100)35 (100)
12.Overdose and management745117 (94)17 (100)34 (97)
13.Warning and precautions745117 (94)17 (100)34 (97)
14.Effect on ability to drive and use machines43209 (50)16 (94)25 (71)
15.Contraindications755118 (100)17 (100)35 (100)
16.Adverse drug reactions755118 (100)17 (100)35 (100)
17.Drug-drug interactions755118 (100)17 (100)35 (100)
18.Drug-food interactions23005 (28)13 (76)18 (51)
19.Pregnancy considerations755118 (100)17 (100)35 (100)
20.Lactation considerations745117 (94)17 (100)34 (97)
21.Pediatric considerations755118 (100)17 (100)35 (100)
22.Geriatric considerations20103 (17)15 (88)18 (51)
23.Possibility of tablet splitting01001 (6)11 (65)12 (34)
24.Possibility of crushing and mixing with food or beverages721111 (61)15 (88)26 (74)
25.Instructions to convert tablets or capsules into liquid forms00000 (0)1 (6)1 (3)
26.Pharmacokinetic information00000 (0)2 (12)2 (6)
27.Shelf life755118 (100)16 (94)34 (97)
28.Storage755118 (100)17 (100)35 (100)
29.Name and address of manufacturers/distributors755118 (100)17 (100)35 (100)
30.Date of last revision00000 (0)13 (76)13 (37)
31.References72009 (50)0 (0)9 (26)